Rifat Pamukcu - Director at Aprea Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
APRE on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Rifat Pamukcu since 12/24/2023

Holdings reported by Rifat Pamukcu for Aprea Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 14.1K $103K $7.29 Jun 20, 2024 By ZNZ Holdings LLC
Common Stock 4.4K $32.1K $7.29 Jun 20, 2024 Direct
Stock Options (Right to Buy) 4.19K Jun 20, 2024 Direct Common Stock
Series A Non-Voting Convertible Preferred Stock 0 Aug 23, 2022 By ZNZ Holdings LLC Common Stock
Series A Non-Voting Convertible Preferred Stock 0 Aug 23, 2022 Direct Common Stock

Transactions reported by Rifat Pamukcu for Aprea Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.